|
Sex (female/male ratio)
|
43/2
|
22/4
|
NS
|
|
Age (years)
|
41 (17-73)
|
37.5 (16-71)
|
NS
|
|
RP duration (years)
|
3 (0.5-24)
|
3 (1-20)
|
NS
|
|
Subset 1: antibody-positive, NVC-positive
|
26 (57.8)
|
6 (2.2)
|
0.0098
|
|
Anti-Scl-70 antibody-positive
|
5 (19.2)
|
0
| |
|
ACA-positive
|
19 (73.1)
|
3 (50)
| |
|
Anti-RNA polymerase III antibody-positive
|
2 (7.7)
|
3 (50)
| |
|
Megacapillaries only
|
21 (80.8)
|
3 (50)
| |
|
Avascular areas ± megacapillaries
|
5 (19.2)
|
3 (50)
| |
|
Subset 2: antibody-positive, NVC-negative
|
16 (35.6)
|
0
|
-
|
|
AntiScl-70 antibody-positive
|
4 (25)
|
0
| |
|
ACA-positive
|
12 (75)
|
0
| |
|
Anti-RNA polymerase III antibody-positive
|
0
|
0
| |
|
Subset 3: antibody-negative, NVC-positive
|
3 (6.7)
|
20 (76.9)
|
0.0001
|
|
Megacapillaries only
|
3 (100)
|
20 (100)
|
-
|
|
Avascular areas ± megacapillaries
|
0
|
0
|
-
|
